TBRI Signs Cooperation Protocol with Badr University in Cairo to Enhance Education, Scientific Research, and Community Service

TBRI Signs Cooperation Protocol with Badr University in Cairo to Enhance Education, Scientific Research, and Community Service

Renewing confidence in Prof. Ahmed Abdel Aziz and assigning him as acting director of TBRI

Professor Mohamed Ayman Ashour, Minister of Higher Education and Scientific Research, has issued a ministerial decree to renew confidence in Prof. Ahmed Mohamed Abdel Aziz Hassan

Towards the Elimination of Schistosomiasis: Theodor Bilharz Institute Trains Medical Personnel in the Latest Diagnostic and Control Techniques

  • 2025-07-29
  • Abdalla Farahat
In a step that reflects the national direction toward institutional integration and the strengthening of efforts to combat endemic diseases, Theodor Bilharz Research Institute (TBRI), under the patronage of Prof. Ahmed Abdel Aziz, Director and Chairman of the Institute, held an advanced training course entitled: "Enhancing Diagnostic Capabilities for Schistosomiasis."

A new scientific achievement for Theodor Bilharz Institute: a patent for the production of therapeutic proteins using biotechnology.

  • 2025-07-28
  • Abdalla Farahat
In a scientific achievement that adds to the record of research successes of  Theodor Bilharz Research Institute, the Egyptian Intellectual Property Authority has approved a patent submitted to the Patent Office, funded by the Science, Technology, and Innovation Funding Authority (STDF), in the field of producing genetically engineered therapeutic proteins using biotechnology.

Prof. Ahmed Abdel- Aziz congratulates Prof.Saber and Prof. El- Dabaa for gaining a patent through STDF

  • 2025-07-27
  • Abdalla Farahat
Professor Ahmed Abdel Aziz, Acting Director of TBRI and Chairman of the Board of Directors, extends his sincere congratulations to Professor Mohamed Ali Saber, Professor in the Department of Biochemistry and Molecular Biology, and Professor Ehab El-Dabaa, Deputy Head of the Division of Biochemistry, Molecular Biology, and Medicinal Chemistry, on the occasion of obtaining a patent from the Science, Technology & Innovation Funding Authority (STDF) in the field of producing genetically engineered therapeutic proteins using biotechnology.
ع